Total pathway to method validation
Clin Chem Lab Med
.
2020 Oct 25;58(11):e257-e261.
doi: 10.1515/cclm-2020-0525.
Authors
Gerald Woollard
1
2
,
Brett McWhinney
1
3
,
Ronda F Greaves
1
4
5
6
7
,
Wilson Punyalack
1
8
Affiliations
1
Member RCPAQAP-AACB Advisory Committees, St Leonards, NSW, Australia.
2
Department of Pathology and Laboratory Medicine, Auckland City Hospital, Auckland, New Zealand.
3
Analytical Chemistry Unit, Department of Chemical Pathology, RBWH, Herston, QLD, Australia.
4
Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, VIC, Australia.
5
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
6
School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
7
Executive, Emerging Technologies Division, International Federation of Clinical Chemistry and Laboratory Medicine, Milan, Italy.
8
The Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP), St Leonards, NSW, Australia.
PMID:
32609639
DOI:
10.1515/cclm-2020-0525
No abstract available
Keywords:
development; method validation; post-development; pre-developmental.
Publication types
Letter
MeSH terms
Humans
Medical Laboratory Personnel
Research Design*